RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay Inc. (AMEX: ISR) today announced it has signed an agreement with BrachySciences, a division of Biocompatibles International plc (LSE: BII), to distribute IsoRay’s Proxcelan Cesium-131 brachytherapy seeds.
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay Inc. (AMEX: ISR) today announced it has signed an agreement with BrachySciences, a division of Biocompatibles International plc (LSE: BII), to distribute IsoRay’s Proxcelan Cesium-131 brachytherapy seeds.